Tag Archives: Boris Peaker

Sutro Biopharma Inc (STRO) Receives a Buy from Cowen & Co.

In a report released yesterday, Boris Peaker from Cowen & Co. maintained a Buy rating on Sutro Biopharma Inc (STRO – Research Report). The company’s shares closed on Friday at $11.20. According to TipRanks.com, Peaker is a 3-star analyst with

MacroGenics (MGNX) Receives a Buy from Cowen & Co.

In a report released today, Boris Peaker from Cowen & Co. maintained a Buy rating on MacroGenics (MGNX – Research Report). The company’s shares closed yesterday at $15.58. According to TipRanks.com, Peaker is a 3-star analyst with an average return

Analysts’ Top Healthcare Picks: ImmunoGen (IMGN), G1 Therapeutics Inc (GTHX)

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on ImmunoGen (IMGN – Research Report) and G1 Therapeutics Inc (GTHX – Research Report) with bullish sentiments. ImmunoGen (IMGN) In a report released

Cowen & Co. Thinks Mersana Therapeutics Inc’s Stock is Going to Recover

Cowen & Co. analyst Boris Peaker maintained a Buy rating on Mersana Therapeutics Inc (MRSN – Research Report) yesterday. The company’s shares closed on Friday at $4.33, close to its 52-week low of $2.85. According to TipRanks.com, Peaker is a

Sutro Biopharma Inc (STRO) Gets a Buy Rating from Cowen & Co.

Cowen & Co. analyst Boris Peaker maintained a Buy rating on Sutro Biopharma Inc (STRO – Research Report) yesterday. The company’s shares closed yesterday at $10.15. According to TipRanks.com, Peaker is a 4-star analyst with an average return of 3.3%

Cowen & Co. Thinks Surface Oncology Inc’s Stock is Going to Recover

In a report released yesterday, Boris Peaker from Cowen & Co. maintained a Buy rating on Surface Oncology Inc (SURF – Research Report). The company’s shares closed yesterday at $4.33, close to its 52-week low of $3.45. According to TipRanks.com,